Jan 23, 2026Cellares targets automated cell therapy manufacturing | Milestone in robotic manufacture of CGTs

Jan 22, 2026Genentech ups NC facility investment to $2B | API development, manufacturing deal

Jan 21, 2026Fujifilm’s investment, expansion roadmap | BMS, Syngene extend long-term pact

Jan 17, 20262026’s optimistic outlook for biopharma | Fresenius Kabi gets cell therapy manufacturing deal

Jan 16, 2026WuXi Biologics’ growth strategy in 2026, beyond | Lotte Biologics inks manufacturing deal

Jan 15, 2026Thermo Fisher benefits from pharma shift to US | WuXi Biologics gets GMP certifications

Jan 14, 20262026 outlook for cell and gene sector | AbbVie pays $175M for Arizona drug-device plant

Jan 13, 2026Biopharma outsourcing in 2026 | Novartis to build fourth US radiotherapy plant

Jan 10, 2026J&J gains tariff exemption in Trump deal | Lonza, Sidewinder team on bispecific ADCs

Jan 9, 20264 CDMOs to watch in 2026 | Rentschler Biopharma, VarmX team on coagulation therapy

Jan 8, 2026Daiichi Sankyo’s $1.9B investment | Ardena, Nouveau Biosciences team on nanomedicine

Jan 7, 2026Taking radiopharma to the next level | ProBioGen, Zag Bio form CMC partnership

Jan 6, 20262026 pharma manufacturing outlook | Skye licenses Halozyme’s drug delivery tech

Dec 31, 2025Top podcast interviews of 2025

Dec 30, 2025Top regulatory stories of 2025

Dec 24, 2025Positive outlook for global CDMOs | Fujifilm’s first antibody drug manufacturing site in Japan

Dec 23, 2025Trump secures pricing deals with more drugmakers | Samsung Biologics buys first US facility

Dec 20, 20252025’s historic US pharma manufacturing investment | Minaris, CGT Catapult team on viral vectors

Dec 19, 2025Novo Nordisk’s problems at former Catalent site continue | Alcami adds manufacturing capacity

Dec 18, 2025Lonza to benefit from supply, demand trends | Alnylam’s $250M biomanufacturing expansion

Dec 17, 2025Startup looks to digitize molecule creation | Thermo Fisher aims to boost E. coli biomanufacturing

Dec 16, 2025BIOSECURE Act to further fuel Indian CRDMOs | Novartis breaks ground on NC expansion

Dec 13, 2025Cambrex targets fast-growing peptide market | Lupin teams to scale peptide supply chain

Dec 12, 2025Manufacturing, supply chain risks in 2026 | Charles River, ElevateBio join Akadeum’s new CDMO alliance

Dec 11, 2025Lilly to build $6B Alabama plant to manufacture APIs | Bora, Corealis unite on oral solid dose

Latest Edition